跳至主要内容
临床试验/NCT03087747
NCT03087747撤回不适用

Percutaneous Drainage in a Setting of Acute Cholecystitis Severity Grade III and Correlation With Clinical Outcomes

University of Split, School of Medicine1 个研究点 分布在 1 个国家开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
C-reactive protein (CRP)

研究概览

简要总结

In a setting of acute cholecystitis (AC) one of the treatment option is percutaneous transhepatic cholangiography (PTHC) drainage. The goal of current study is to evaluate some radiology aspects and correlate with clinical patient outcomes in patients with acute cholecystitis severity grade III (presented as acute cholecystitis with organ dysfunction).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • clinical markers of acute cholecystitis
  • diagnosis confirmed with some imaging technique: computed tomography (CT), ultrasound (US).

排除标准

  • clinical diagnosis was not confirmed with imaging.

结局指标

主要结局

C-reactive protein (CRP)

时间窗: Up to 8 weeks.

C-reactive protein (CRP) is a protein found in blood plasma, whose levels rise in response to inflammation.

次要结局

  • White blood cells (WBCs) count(Up to 8 weeks.)
  • Drainage duration (expressed in days)(Up to 16 weeks.)

研究者

发起方
University of Split, School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marija Cavar

MD

University of Split, School of Medicine

研究点 (1)

Loading locations...

相似试验